Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FX006 (Zilretta) vs TCA IR in Knee Osteoarthritis
NCT01487161Phase 2Completed
- Sponsor
- Pacira BioSciences
- Start
- Jun 2012
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of triamcinolone acetonide in knee osteoarthritis (OA), sponsored by Pacira BioSciences. Started Jun 2012; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01487161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01487161.